{
  "meta": {
    "title": "Corneal_Ulcers",
    "url": "https://brainandscalpel.vercel.app/corneal-ulcers-4069abc8.html",
    "scrapedAt": "2025-11-29T18:31:14.754Z"
  },
  "questions": [
    {
      "id": 15390,
      "choices": [
        {
          "id": 61520,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cefazolin </span></span></span></p>"
        },
        {
          "id": 61521,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chlorhexidine </span></span></span></p>"
        },
        {
          "id": 61522,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tobramycin </span></span></span></p>"
        },
        {
          "id": 61523,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Voriconazole</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old woman who regularly wears contact lenses came to the ophthalmologist with complaints of severe pain in right eye along with redness and blurring of vision since the past few days. Her eye is shown below. Which of the following given options can be considered for her treatment?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/10/c29.jpg\" style=\"height:198px; width:300px\" /></p>",
      "unique_key": "Q2011947",
      "question_audio": null,
      "question_video": null,
      "map_id": 31366,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Chlorhexidine </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The picture given is characteristic of <strong>acanthamoeba keratitis (ring infiltrate)</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acanthamoeba keratitis is most frequently associated with <strong>contact lens wear</strong>, especially if <strong>tap water</strong> is used for <strong>rinsing</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">TREATMENT OPTIONS:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Topical Amoebicides such as:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Poly-Hexa-Methylene Biguanide (PHMB) 0.02% </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chlorhexidine 0.02% </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hexamidine </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propamidine </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Cefazolin is a <strong>cephalosporin antibiotic</strong> used against a range of bacterial infections. However, it is not effective against Acanthamoeba and is not used in the treatment of Acanthamoeba keratitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Tobramycin is an <strong>aminoglycoside antibiotic</strong>. While it is effective against various bacterial infections and is commonly used in <strong>treating bacterial keratitis</strong>, it is not effective against Acanthamoeba.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Voriconazole is an <strong>antifungal medication</strong>. While it has a <strong>broad spectrum</strong> of <strong>activity</strong>, its use in <strong>Acanthamoeba keratitis</strong> is more limited. It may be considered in certain cases, particularly for <strong>fungal co-infections</strong>, but it&#39;s not a first-line treatment for Acanthamoeba.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">:</span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For the treatment of Acanthamoeba keratitis, chlorhexidine is <strong>considered effective</strong> and is commonly used, as <strong>opposed</strong> to <strong>antibiotics</strong> like <strong>cefazolin</strong> and <strong>tobramycin</strong> or <strong>antifungals</strong> like voriconazole, which are not primarily effective against this protozoan infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: KANSKI 9<sup>TH</sup> EDITION PAGE 232</span></strong></span></span></p>",
      "correct_choice_id": 61521,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15388,
      "choices": [
        {
          "id": 61512,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Natamycin </span></span></span></p>"
        },
        {
          "id": 61513,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amphotericin </span></span></span></p>"
        },
        {
          "id": 61514,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fluconazole </span></span></span></p>"
        },
        {
          "id": 61515,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Voriconazole</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old farmer came to the ophthalmologist with complaints of a pain, redness, increased sensitivity to light and blurring of vision in left eye. He gave history of ocular trauma with a twig, 1 day back. After examination, the ophthalmologist suspects fungal keratitis and takes corneal scrapings to confirm her diagnosis. The following organism is observed under the microscope for which immediate treatment is to be initiated to prevent further corneal damage. What is the drug of choice in this case?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/10/c28.jpg\" style=\"height:202px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q4972846",
      "question_audio": null,
      "question_video": null,
      "map_id": 31364,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Natamycin </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given picture shows <strong>filamentous fungi</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Fusarium</span></strong><span style=\"font-size:12.0pt\"> and <strong>Aspergillus</strong> are the <strong>filamentous fungi</strong> implicated in <strong>fungal keratitis</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The drug of choice is <strong>Natamycin 5%.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other treatment options include <strong>amphotericin B 0.15%</strong>, <strong>miconazole 1%</strong> and <strong>voriconazole 1%</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Amphotericin B is more commonly used for <strong>yeast-like fungal infections</strong> (e.g., Candida) rather than filamentous fungal infections. It can be used in certain cases of <strong>severe</strong> or <strong>resistant fungal keratitis</strong>, but it is not the first choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Fluconazole is <strong>effective against yeasts</strong> but has limited activity against filamentous fungi. It is not typically the first-line treatment for filamentous fungal corneal ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Voriconazole is a <strong>broad-spectrum antifungal</strong> that can be effective against a wide range of fungi, including filamentous fungi. It is sometimes used in cases where <strong>natamycin</strong> is <strong>ineffective</strong> or the fungus is known to be resistant to <strong>natamycin</strong>. However, natamycin remains the first-line treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">:</span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the management of filamentous fungal corneal ulcers, natamycin is the treatment of choice due to its <strong>effectiveness against common filamentous fungi</strong> that cause these <strong>infections</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: KANSKI 9<sup>TH</sup> EDITION PAGE 218 </span></strong></span></span></p>",
      "correct_choice_id": 61512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15411,
      "choices": [
        {
          "id": 61604,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lignocaine </span></span></span></p>"
        },
        {
          "id": 61605,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bupivacaine </span></span></span></p>"
        },
        {
          "id": 61606,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Proparacaine </span></span></span></p>"
        },
        {
          "id": 61607,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prilocaine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old female came to the ophthalmologist with complaints of a pain in the eye and blurring of vision. She was diagnosed with a corneal ulcer and was sent for corneal scraping. Which of the following topical anaesthetic agents is preferred for the planned procedure?</span></span></p>",
      "unique_key": "Q9064230",
      "question_audio": null,
      "question_video": null,
      "map_id": 31362,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Proparacaine </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Topical proparacaine <strong>does not inhibit growth</strong> of <strong>staphylococcus</strong>, <strong>candida</strong> or <strong>pseudomonas</strong>. Hence preferred compared to other drugs before scraping a corneal ulcer for culture study.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lignocaine is a commonly used <strong>local anesthetic</strong> in various medical procedures, including ophthalmology. However, it is <strong>not the first choice</strong> for corneal scraping due to its <strong>stinging sensation</strong> and <strong>relatively longer duration of action</strong>, which might not be ideal in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Bupivacaine is a <strong>long-acting local anesthetic</strong>. Its <strong>longer duration</strong> and <strong>stronger anesthetic effect</strong> make it <strong>less ideal for short procedures</strong> like corneal scraping, where a quick onset and short duration of action are preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Prilocaine is another <strong>local anesthetic</strong>, but it is not commonly used in ophthalmology for procedures like corneal scraping. It&#39;s more often <strong>used in dentistry</strong> and for <strong>nerve block anesthesia</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">:</span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For the procedure of corneal scraping in the treatment of corneal ulcers, <strong>proparacaine</strong> is the <strong>preferred topical anesthetic agent</strong> due to its <strong>rapid onset of action</strong> and <strong>short duration</strong>, which are <strong>suitable</strong> for this <strong>brief</strong> and <strong>delicate procedure</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: AAO SECTION: 2 &ndash; 2020 EDITION PAGE 412</span></strong></span></span></p>",
      "correct_choice_id": 61606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15437,
      "choices": [
        {
          "id": 61708,
          "text": "<p><span style=\"font-size:12.0pt;\">Nodular Episcleritis</span></p>"
        },
        {
          "id": 61709,
          "text": "<p><span style=\"font-size:12.0pt;\">Nodular Scleritis</span></p>"
        },
        {
          "id": 61710,
          "text": "<p><span style=\"font-size:12.0pt;\">Necrotising Scleritis</span></p>"
        },
        {
          "id": 61711,
          "text": "<p><span style=\"font-size:12.0pt;\">Diffuse Scleritis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old female who is a known case of rheumatoid arthritis presents with pain, redness and watering in right eye. On evaluation she had a dark red swelling in the temporal aspect. What is the likely diagnosis?</span></p>",
      "unique_key": "Q2601158",
      "question_audio": null,
      "question_video": null,
      "map_id": 31360,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Nodular Scleritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Nodular scleritis – <strong>less circumscribed nodule</strong> noted</span></li><li><span style=\"font-size:12.0pt;\">The swelling is at <strong>first dark red</strong> or <strong>bluish</strong> and later becomes <strong>purple</strong> and <strong>semi-transparent</strong> like porcelain. <strong>Deeper blue-red colour</strong> than <strong>episcleritis</strong> and are immobile also.</span></li><li><span style=\"font-size:12.0pt;\">It may extend entirely around the cornea, forming a <strong>very serious condition</strong> known as <strong>annular scleritis</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Most common association of Scleritis is <strong>Rheumatoid arthritis.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/16/picture31.jpg\" alt=\"\" width=\"500\" height=\"291\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Nodular episcleritis: <strong>Non</strong>-<strong>Tender red vascular mobile nodule</strong> is seen within <strong>interpalpebral fissure</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/16/picture32.jpg\" alt=\"\" width=\"500\" height=\"375\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>Necrotising scleritis<strong>:</strong> <strong>Serious</strong> and <strong>aggressive form</strong> of <strong>Scleritis</strong>. Gradual onset of <strong>pain</strong> that becomes <strong>severe</strong> and <strong>persistent</strong> and <strong>radiates</strong> to the <strong>temple, brow</strong> or <strong>jaw</strong>. It would present as thinning and uveal show would be present, unlike nodular scleritis, which presents as a reddish nodule.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/16/picture33.jpg\" alt=\"\" width=\"800\" height=\"402\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Diffuse scleritis: <strong>Ocular redness</strong> progresses to a <strong>pain</strong> that may <strong>radiate</strong> to <strong>face</strong> and <strong>temple</strong>. Can involve more than one quadrant of sclera.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/16/picture34.jpg\" alt=\"\" width=\"500\" height=\"335\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nodular scleritis is commonly associated with <strong>rheumatoid arthritis</strong>.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: PARSON’S DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 226</strong></span></p><p>&nbsp;</p><p>&nbsp;</p>",
      "correct_choice_id": 61709,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15438,
      "choices": [
        {
          "id": 61712,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sclerosing Keratitis </span></span></span></p>"
        },
        {
          "id": 61713,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Corneal Opacity </span></span></span></p>"
        },
        {
          "id": 61714,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Keratolysis </span></span></span></p>"
        },
        {
          "id": 61715,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corneal Vascularisation</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 49-year-old female came to the ophthalmologist with redness in her eyes since a few days and a new-onset pain which radiates to face and temple. On examination, bluish-red congestion is seen in the conjunctiva, involving 2 quadrants of the sclera. A diagnosis of Scleritis is made. What is the most serious corneal complication that can occur?</span></span></p>",
      "unique_key": "Q7553718",
      "question_audio": null,
      "question_video": null,
      "map_id": 31361,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Keratolysis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">COMPLICATIONS OF SCLERITIS: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sclerosing keratitis </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Keratolysis (most serious)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Staphyloma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Secondary glaucoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uveitis </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Complicated cataract </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Sclerosing keratitis refers to <strong>corneal inflammation</strong> and <strong>scarring</strong>. While it can be a complication of scleritis, it is not the most serious corneal complication associated with scleritis. It can cause <strong>vision impairment</strong> but is generally less severe than keratolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/16/picture35.jpg\" style=\"height:409px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Corneal opacity is a <strong>clouding</strong> or <strong>loss of transparency</strong> in the <strong>cornea</strong>, which can occur as a result of various eye conditions, including <strong>inflammation</strong>. While scleritis can lead to <strong>corneal opacity</strong>, it is not the most serious corneal complication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Corneal vascularization is the <strong>growth</strong> of <strong>blood vessels</strong> into the <strong>corneal stroma</strong>, often in response to <strong>injury</strong> or <strong>inflammation</strong>. While it can occur in <strong>scleritis</strong>, it is not the most severe corneal complication associated with the condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/16/picture36.jpg\" style=\"height:378px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most serious corneal complication of scleritis is <strong>Keratolysis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: PARSON&rsquo;S DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 227</span></strong></span></span></p>",
      "correct_choice_id": 61714,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15450,
      "choices": [
        {
          "id": 61760,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diffuse Anterior Scleritis </span></span></span></p>"
        },
        {
          "id": 61761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nodular Anterior Sscleritis </span></span></span></p>"
        },
        {
          "id": 61762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Necrotizing Scleritis with Inflammation </span></span></span></p>"
        },
        {
          "id": 61763,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Necrotizing Scleritis without Inflammation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which form of anterior scleritis presents like this?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/10/c39.jpg\" style=\"height:199px; width:300px\" /></span></span></p>",
      "unique_key": "Q2379979",
      "question_audio": null,
      "question_video": null,
      "map_id": 31363,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Necrotizing Scleritis with Inflammation </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/16/screenshot-2024-01-16-125310.jpg\" style=\"height:547px; width:700px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: PARSON&rsquo;S DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 227</span></strong></span></span></p>",
      "correct_choice_id": 61762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15453,
      "choices": [
        {
          "id": 61772,
          "text": "<p><span style=\"font-size:12.0pt;\">Effective mode of treatment is administration of systemic steroids</span></p>"
        },
        {
          "id": 61773,
          "text": "<p><span style=\"font-size:12.0pt;\">Sub conjunctival injections of steroids are beneficial</span></p>"
        },
        {
          "id": 61774,
          "text": "<p><span style=\"font-size:12.0pt;\">Local steroids are not effective</span></p>"
        },
        {
          "id": 61775,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic NSAIDs can be given</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 45-year-old woman presents with a three-week history of progressively worsening ocular symptoms. She complains of severe, deep, and boring pain in her right eye, which increases with eye movements. She also notices a gradual onset of decreased vision in the same eye. On examination, there is mild redness and tenderness around the eye, along with proptosis. Fundoscopic examination reveals choroidal folds and swelling of the optic disc. Ultrasonography confirms the diagnosis of posterior scleritis. All the statements given regarding her treatment are true, except?</span></p>",
      "unique_key": "Q1363051",
      "question_audio": null,
      "question_video": null,
      "map_id": 31365,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Local steroids are not effective.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong>Ideal treatment for diffuse or nodular scleritis would be</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Oral NSAIDS</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Oral prednisolone 1 mg/kg</strong> as a single dose in the morning for one week which can then be tapered to 20 mg per day over the subsequent 2–3 weeks, or immunosuppressive agents</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ideal treatment for necrotizing scleritis would be</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Systemic steroids&nbsp;</strong>and <strong>immunosuppressives</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Abundant lubricants&nbsp;</strong>are important in <strong>scleromalaciaperforans</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ideal treatment for posterior scleritis,</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Systemic NSAIDs, steroids&nbsp;</strong>or <strong>immunosuppressive therapy</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Intravenous methylprednisolone administered as <strong>pulse therapy</strong> is also effective.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Effective mode of treatment is administration of systemic steroids:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">True. Systemic steroids, such as <strong>oral prednisone</strong>, are often the <strong>mainstay</strong> of <strong>treatment</strong> for <strong>posterior</strong> <strong>scleritis</strong> to <strong>reduce inflammation</strong> and <strong>alleviate symptoms</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Subconjunctival injections of steroids are beneficial:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">True. In some cases, <strong>subconjunctival injections</strong> of <strong>steroids</strong> may be used as an <strong>adjunctive treatment</strong> to provide <strong>localized anti-inflammatory effects</strong>. However, this is usually done in addition to systemic treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Systemic NSAIDs can be given:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">True. Systemic nonsteroidal anti-inflammatory drugs (NSAIDs) can be used as an <strong>alternative</strong> or <strong>adjunctive therapy</strong> in the <strong>management</strong> of <strong>posterior scleritis</strong>, especially in cases where systemic steroids may not be suitable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Systemic steroids</strong> and <strong>NSAIDs</strong> form the mainstay of treatment of <strong>posterior scleritis</strong>. Posterior subtenon’s injection of steroids are effective in recalcitrant cases.&nbsp;</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: PARSON’S DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 228</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>2. Dutta Majumder, Parthopratim; Agrawal, Rupesh; McCluskey, Peter; Biswas, Jyotirmay. Current Approach for the Diagnosis and Management of Noninfective Scleritis. Asia-Pacific Journal of Ophthalmology 10(2):p 212-223, March-April 2021. | DOI: 10.1097/APO.0000000000000341</strong></span></p>",
      "correct_choice_id": 61774,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15456,
      "choices": [
        {
          "id": 61784,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Marginal Corneal Ulcer </span></span></span></p>"
        },
        {
          "id": 61785,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Secondary Glaucoma </span></span></span></p>"
        },
        {
          "id": 61786,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scleromalacia Perforans</span></span></span></p>"
        },
        {
          "id": 61787,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Degenerative Myopia</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The differentials for underlying etiology exclude which of the following options?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/10/c42.jpg\" style=\"height:207px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6261507",
      "question_audio": null,
      "question_video": null,
      "map_id": 31358,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Degenerative Myopia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given picture is characteristic of <strong>INTERCALARY STAPHYLOMA</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Location &ndash; at the <strong>limbus</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is lined by the <strong>root</strong> of the <strong>iris</strong> and the <strong>anterior</strong> most part of the <strong>ciliary body</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Extent &ndash; from <strong>limbus</strong> to <strong>up to 2 mm</strong> behind the limbus. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CAUSES: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Perforating injuries&nbsp;</span></strong><span style=\"font-size:12.0pt\">of the <strong>peripheral cornea</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Marginal</span></strong><span style=\"font-size:12.0pt\"> <strong>corneal ulcer</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anterior scleritis</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Scleromalaciaperforans</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Complicated cataract surgery with <strong>poor wound apposition</strong> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Secondary glaucoma</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Degenerative myopia can lead to <strong>Posterior Staphyloma</strong> (<strong>peripapillary</strong> or <strong>macular ectasia</strong> of the <strong>posterior sclera</strong>).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Marginal corneal ulcer: Corneal ulcers can lead to <strong>tissue damage</strong> and <strong>thinning</strong> in the <strong>cornea</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Secondary Glaucoma: Can lead to formation of <strong>intercalary staphyloma</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Scleromalaciaperforans: Scleromalaciaperforans is a condition characterized by <strong>thinning</strong> and <strong>weakening</strong> of the <strong>sclera</strong>. It can lead to <strong>staphyloma formation</strong>, including <strong>intercalary staphyloma</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Degenerative myopia&nbsp;</span></strong><span style=\"font-size:12.0pt\">(also known as <strong>pathological</strong> or <strong>malignant myopia</strong>): This condition involves <strong>excessive axial elongation</strong> of the <strong>eyeball</strong>, which can result in <strong>thinning</strong> of the <strong>posterior sclera</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: PARSON&rsquo;S DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 229</span></strong></span></span></p>",
      "correct_choice_id": 61787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15457,
      "choices": [
        {
          "id": 61788,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pilocarpine </span></span></span></p>"
        },
        {
          "id": 61789,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phenylephrine </span></span></span></p>"
        },
        {
          "id": 61790,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atropine </span></span></span></p>"
        },
        {
          "id": 61791,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proparacaine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following topical drugs can be used to differentiate episcleritis from scleritis:</span></span></p>",
      "unique_key": "Q9627908",
      "question_audio": null,
      "question_video": null,
      "map_id": 31359,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Phenylephrine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Instillation of <strong>10% phenylephrine drops</strong> will <strong>constrict</strong> the <strong>conjunctival</strong> and <strong>superficial episcleral vasculature</strong> but not the deep plexus overlying the nodule &ndash; hence in <strong>episcleritis blanching occurs</strong> but not in scleritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Pilocarpine is a <strong>miotic agent</strong> that <strong>constricts</strong> the <strong>pupil</strong> and is primarily used to treat conditions like glaucoma. It is not typically used for differentiating episcleritis from scleritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Atropine is a <strong>mydriatic agent</strong> like phenylephrine but it doesnot have vasoconstrictor properties.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Proparacaine is a <strong>topical anesthetic</strong>. It is not used for differentiating between episcleritis and scleritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The topical drug used to <strong>differentiate episcleritis</strong> from <strong>scleritis</strong> is <strong>Phenylephrine</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: KANSKI 9<sup>TH</sup> EDITION PAGE 294 </span></strong></span></span></p>",
      "correct_choice_id": 61789,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}